Peripheral neuropathy - A haematological or lymphoproliferative disorder Factor

Last reviewed for CCPS 15 March 2006.

Preliminary questions [32701]

32702 [2] there is some evidence that having a haematological or lymphoproliferative disorder may be a factor in the development of the condition under consideration.

32703 — the veteran has had a haematological or lymphoproliferative disorder at some time.

32716 [3] the veteran has had acute lymphoid leukaemia at some time.

or

32717 [4] the veteran has had acute myeloid leukaemia at some time.

or

31280 [5] the veteran has had chronic lymphoid leukaemia at some time.

or

32719 [6] the veteran has had chronic myeloid leukaemia at some time.

or

7429 [7] the veteran has had Hodgkin's lymphoma at some time.

or

32711 [8] the veteran has had monoclonal gammopathy at some time.

or

32714 [9] the veteran has had myeloma at some time.

or

7436 [10] the veteran has had non-Hodgkin's lymphoma at some time.

or

5604 [11] the veteran has had polycythaemia vera at some time.

or

32715 [12] the veteran has had Waldenstrom's macroglobulinaemia at some time.

32705 [13] the veteran had the identified illness or injury, a haematological or lymphoproliferative disorder, at the time of the clinical onset of peripheral neuropathy. [14]

32706 — the veteran has established the causal connection between the haematological or lymphoproliferative disorder and VEA service for the clinical onset of peripheral neuropathy.

32707 — the veteran has established the causal connection between the haematological or lymphoproliferative disorder and operational service for the clinical onset of peripheral neuropathy.

or

32708 — the veteran has established the causal connection between the haematological or lymphoproliferative disorder and eligible service for the clinical onset of peripheral neuropathy.

Clinical onset and operational service [32707]

32709 — the identified illness or injury, a haematological or lymphoproliferative disorder, is causally related to operational service. [15] [16]

Clinical onset and eligible service [32708]

32710 — the identified illness or injury, a haematological or lymphoproliferative disorder, is causally related to eligible service. [17] [16]

Peripheral neuropathy - A nutritional deficiency Factor

Last reviewed for CCPS 15 March 2006.

Investigative Documents

Medical Report - Nutritional Deficiency - Peripheral neuropathy [MR9291]

Preliminary questions [32879]

[18]32880

there is some evidence that a nutritional deficiency may be a factor in the development of the condition under consideration.

32881 [19] the veteran had a nutritional deficiency at the time of the clinical onset of the condition under consideration.

32883 — the veteran has established the causal connection between the nutritional deficiency and VEA service for the clinical onset of peripheral neuropathy.

32884 — the veteran has established the causal connection between the nutritional deficiency and operational service for the clinical onset of peripheral neuropathy.

or

32885 — the veteran has established the causal connection between the nutritional deficiency and eligible service for the clinical onset of peripheral neuropathy.

Clinical onset and operational service [32884]

[20]32886

as a causal result of operational service, the veteran suffered from a nutritional deficiency at the time of the clinical onset of the condition under consideration.

or

[21]32888

the veteran suffered from a nutritional deficiency at the time of the clinical onset of the condition under consideration as a consequence of an illness or injury which is identifiable.

32889 — the identified illness or injury which caused the nutritional deficiency is causally related to operational service. [22] [23]

Clinical onset and eligible service [32885]

[24]32893

as a causal result of eligible service, the veteran suffered from a nutritional deficiency at the time of the clinical onset of the condition under consideration.

or

[25]32888

the veteran suffered from a nutritional deficiency at the time of the clinical onset of the condition under consideration as a consequence of an illness or injury which is identifiable. [22]

32890 — the identified illness or injury which caused the nutritional deficiency is causally related to eligible service. [26] [23]

Peripheral neuropathy - A systemic disease for peripheral neuropathy Factor

Last reviewed for CCPS 15 March 2006.

Preliminary questions [32669]

32670 [27] there is some evidence that suffering from a systemic disease from the specified list of diseases for peripheral neuropathy may be a factor in the development of the condition under consideration.

35703 — the veteran has had a systemic disease for peripheral neuropathy at some time.

10714 [28] the veteran has had acromegaly at some time.

or

17349 [29] the veteran has suffered from amyloidosis at some time.

or

35701 [30] the veteran has chronic liver failure.

or

626 [31] the veteran has chronic renal failure.

or

22818 [32] the veteran suffered from coeliac disease at some time.

or

32680 [33] the veteran has suffered from hypereosinophilic syndrome at some time.

or

806 [34] the veteran has had ulcerative colitis.

or

[35]3717

the veteran has Crohn's disease.

or

17912 [36] the veteran has had sarcoidosis at some time.

32673 — the veteran has established the causal connection between suffering from a systemic disease from the specified list of diseases for peripheral neuropathy and VEA service for the clinical onset of peripheral neuropathy.

32674 — the veteran has established the causal connection between suffering from a systemic disease from the specified list of diseases for peripheral neuropathy and operational service for the clinical onset of peripheral neuropathy.

or

32675 — the veteran has established the causal connection between suffering from a systemic disease from the specified list of diseases for peripheral neuropathy and eligible service for the clinical onset of peripheral neuropathy.

Clinical onset and operational service [32674]

32672 [37] the veteran suffered from the identified illness or injury, a systemic disease from the specified list of diseases for peripheral neuropathy, at the time of the clinical onset of the condition under consideration.

32676 — the identified illness or injury, a systemic disease from the specified list of diseases for peripheral neuropathy, is causally related to operational service. [38] [39]

Clinical onset and eligible service [32675]

[40]35704

the identified illness or injury, a systemic disease from the specified list of diseases for peripheral neuropathy, is one of the diseases available in eligible service cases.

[41]32672

the veteran suffered from the identified illness or injury, a systemic disease from the specified list of diseases for peripheral neuropathy, at the time of the clinical onset of the condition under consideration. [38]

32677 — the identified illness or injury, a systemic disease from the specified list of diseases for peripheral neuropathy, is causally related to eligible service. [42] [39]

Peripheral neuropathy - A systemic vasculitis Factor

Last reviewed for CCPS 15 March 2006.

Preliminary questions [32713]

32721 [43] there is some evidence that a systemic vasculitis may be a factor in the development of the condition under consideration.

32722 — the veteran has had a systemic vasculitis at some time.

35705 [44] the veteran has had allergic angiitis at some time.

or

35706 [44] the veteran has had Churg-Strauss syndrome at some time.

or

35707 [45] the veteran has had cryoglobulimaemia at some time.

or

35708 [46] the veteran has had giant cell (temporal) arteritis at some time.

or

12636 [47] the veteran has had polyarteritis nodosa at some time.

or

10037 [48] the veteran has had Wegener's granulomatosis at some time.

32723 [49] the veteran had the identified illness or injury, a systemic vasculitis, at the time of the clinical onset of peripheral neuropathy. [50]

32724 — the veteran has established the causal connection between the systemic vasculitis and VEA service for the clinical onset of peripheral neuropathy.

32725 — the veteran has established the causal connection between the systemic vasculitis and operational service for the clinical onset of peripheral neuropathy.

or

32726 — the veteran has established the causal connection between the systemic vasculitis and eligible service for the clinical onset of peripheral neuropathy.

Clinical onset and operational service [32725]

32727 — the identified illness or injury, a systemic vasculitis, is causally related to operational service. [51] [52]

Clinical onset and eligible service [32726]

32728 — the identified illness or injury, a systemic vasculitis, is causally related to eligible service. [53] [52]

Peripheral neuropathy - A viral or bacterial or protozoal infection Factor

Last reviewed for CCPS 15 March 2006.

Preliminary questions [32730]

32731 [54] there is some evidence that a viral, bacterial or protozoal infection may be a factor in the development of the condition under consideration.

35710 — the veteran has had a viral, bacterial or protozoal infection for peripheral neuropathy at some time.

35712 [55] the veteran has had Lyme disease at some time.

or

35713 [56] the veteran has had botulism at some time.

or

35714 [57] the veteran has had diphtheria at some time.

or

2794 [58] the veteran has hepatitis C.

or

2464 [59] the veteran has been infected with the human immunodeficiency virus (HIV).

or

1670 [60] the veteran has been infected with HTLV-1.

or

35715 [61] the veteran has had leprosy at some time.

or

27464 [62] the veteran has suffered from tertiary syphilis at some time.

or

35716 [63] the veteran has had Chagas' disease at some time.

32734 — the veteran has established the causal connection between having a viral, bacterial or protozoal infection and VEA service for the clinical onset of the condition under consideration.

32735 — the veteran has established the causal connection between a viral, bacterial or protozoal infection and operational service for the clinical onset of the condition under consideration.

or

32736 — the veteran has established the causal connection between a viral, bacterial or protozoal infection and eligible service for the clinical onset of the condition under consideration.

Clinical onset and operational service [32735]

32733 [64] the veteran was suffering from the identified illness or injury, a viral, bacterial or protozoal infection for peripheral neuropathy, at the time of the clinical onset of the condition under consideration.

32737 — the identified illness or injury, a viral, bacterial or protozoal infection for peripheral neuropathy, is causally related to operational service. [65] [66]

Clinical onset and eligible service [32736]

[67]35711

the identified illness or injury, a viral, bacterial or protozoal infection for peripheral neuropathy, is one of the infections available in eligible service cases.

[68]32733

the veteran was suffering from the identified illness or injury, a viral, bacterial or protozoal infection for peripheral neuropathy, at the time of the clinical onset of the condition under consideration. [65]

32738 — the identified illness or injury, a viral, bacterial or protozoal infection for peripheral neuropathy, is causally related to eligible service. [69] [66]

Peripheral neuropathy - Acute cholinergic poisoning Factor

Last reviewed for CCPS 15 March 2006.

Investigative Documents

Medical Report - Acute Cholinergic Poisoning - Peripheral neuropathy [MR9289]

Preliminary questions [35742]

[70]35754

there is some evidence that acute cholinergic poisoning may be a factor in the development of the condition under consideration.

35755 [71] the veteran had an episode of acute cholinergic poisoning within the 30 days before the clinical onset of the condition under consideration.

35757 — the veteran has established the causal connection between acute cholinergic poisoning and VEA service for the clinical onset of peripheral neuropathy.

35758 — the veteran has established the causal connection between acute cholinergic poisoning and operational service for the clinical onset of peripheral neuropathy.

or

35759 — the veteran has established the causal connection between acute cholinergic poisoning and eligible service for the clinical onset of peripheral neuropathy.

Clinical onset and operational service [35758]

[72]35760

the veteran's episode of acute cholinergic poisoning within the 30 days before the clinical onset of the condition under consideration arose from exposure to an organophosphorus ester or a carbamate pesticide.

[73]35762

on operational service, the veteran had an episode of acute cholinergic poisoning from exposure to an organophosphorus ester or a carbamate pesticide within the 30 days before the clinical onset of the condition under consideration.

[74]35763

the veteran's episode of acute cholinergic poisoning from exposure to an organophosphorus ester or a carbamate pesticide, on operational service, was due to the veteran's serious default, wilful act or serious breach of discipline.

or

[75]35767

the veteran had an episode of acute cholinergic poisoning within the 30 days before the clinical onset of the condition under consideration as a consequence of an illness or injury which is identifiable.

35768 — the identified illness or injury, as a consequence of which the veteran had an episode of acute cholinergic poisoning from exposure to an organophosphorus ester or a carbamate pesticide, is causally related to operational service. [76]

Clinical onset and eligible service [35759]

[77]35761

the veteran's episode of acute cholinergic poisoning within the 30 days before the clinical onset of the condition under consideration arose from exposure to an organophosphorus ester.

[78]35764

on eligible service, the veteran had an episode of acute cholinergic poisoning from exposure to an organophosphorus ester within the 30 days before the clinical onset of the condition under consideration.

[79]35765

as a causal result of eligible service, the veteran had an episode of acute cholinergic poisoning from exposure to an organophosphorus ester within the 30 days before the clinical onset of the condition under consideration.

[80]35766

the veteran's episode of acute cholinergic poisoning from exposure to an organophosphorus ester, on eligible service, was due to the veteran's serious default, wilful act or serious breach of discipline.

or

[75]35767

the veteran had an episode of acute cholinergic poisoning within the 30 days before the clinical onset of the condition under consideration as a consequence of an illness or injury which is identifiable.

35769 — the identified illness or injury, as a consequence of which the veteran had an episode of acute cholinergic poisoning from exposure to an organophosphorus ester, is causally related to eligible service. [81] [82]

Peripheral neuropathy - Alcohol consumption Factor

Last reviewed for CCPS 15 March 2006.

Investigative Documents

Claimant Report - Alcohol Consumption [CRD904]

[83] Claimant Report - Alcohol Consumption [CRV904]

[84] Medical Report - Alcohol Consumption [MR9244]

Preliminary questions [32654]

[85]25686

the veteran has consumed alcohol at some time.

32656 — the veteran has established the causal connection between the alcohol consumption and VEA service for the clinical onset of peripheral neuropathy.

32657 — the veteran has established the causal connection between the alcohol consumption and operational service for the clinical onset of peripheral neuropathy.

or

32658 — the veteran has established the causal connection between the alcohol consumption and eligible service for the clinical onset of peripheral neuropathy.

Clinical onset and operational service [32657]

[86]32659

the veteran consumed at least 350 kg of alcohol within the 10 years before the clinical onset of the condition under consideration.

[87]32660

operational service made a material contribution to the veteran's consumption of at least 350 kg of alcohol within the 10 years before the clinical onset of the condition under consideration.

[88]32662

the veteran's consumption of at least 350 kg of alcohol within the 10 years before the clinical onset of the condition under consideration, which was materially contributed by operational service, was due to the veteran's serious default, wilful act or serious breach of discipline.

Clinical onset and eligible service [32658]

[89]32664

the veteran consumed at least 700 kg of alcohol within the 10 years before the clinical onset of the condition under consideration.

[90]32665

eligible service made a material contribution to the veteran's consumption of at least 700 kg of alcohol within the 10 years before the clinical onset of the condition under consideration.

[91]32667

the veteran's consumption of at least 700 kg of alcohol within the 10 years before the clinical onset of the condition under consideration, which was materially contributed by eligible service, was due to the veteran's serious default, wilful act or serious breach of discipline. [89]

Peripheral neuropathy - Alcohol dependence or alcohol abuse Factor

Last reviewed for CCPS 15 March 2006.

Preliminary questions [35696]

25223 [92] the veteran has had alcohol dependence or alcohol abuse at some time.

35697 [93] the veteran had alcohol dependence or alcohol abuse at the time of the clinical onset of the condition under consideration. [94]

35698 — the veteran has established the causal connection between the alcohol dependence or alcohol abuse and VEA service for the clinical onset of peripheral neuropathy.

35699 — the veteran has established the causal connection between the alcohol dependence or alcohol abuse and operational service for the clinical onset of peripheral neuropathy.

or

35700 — the veteran has established the causal connection between the alcohol dependence or alcohol abuse and eligible service for the clinical onset of peripheral neuropathy.

Clinical onset and operational service [35699]

26519 — the alcohol dependence or alcohol abuse is causally related to operational service. [95] [96]

Clinical onset and eligible service [35700]

26522 — the alcohol dependence or alcohol abuse is causally related to eligible service. [97] [96]

Peripheral neuropathy - An inflammatory connective tissue disease Factor

Last reviewed for CCPS 15 March 2006.

Preliminary questions [32712]

32684 [98] there is some evidence that an inflammatory connective tissue disease may be a factor in the development of the condition under consideration.

32685 — the veteran has had an inflammatory connective tissue disease at some time.

8617 [99] the veteran has had mixed connective tissue disease at some time.

or

20038 [100] the veteran has had rheumatoid arthritis at some time.

or

6563 [101] the veteran has had scleroderma at some time.

or

8615 [102] the veteran has had Sjogren's syndrome at some time.

or

2576 [103] the veteran has had systemic lupus erythematosus at some time.

[104]32671

the veteran had the identified illness or injury, an inflammatory connective tissue disease, at the time of the clinical onset of peripheral neuropathy. [105]

32687 — the veteran has established the causal connection between the inflammatory connective tissue disease and VEA service for the clinical onset of the condition under consideration.

32688 — the veteran has established the causal connection between the inflammatory connective tissue disease and operational service for the clinical onset of the condition under consideration.

or

32689 — the veteran has established the causal connection between the inflammatory connective tissue disease and eligible service for the clinical onset of the condition under consideration.

Clinical onset and operational service [32688]

32690 — the identified illness or injury, an inflammatory connective tissue disease, is causally related to operational service. [106] [107]

Clinical onset and eligible service [32689]

32691 — the identified illness or injury, an inflammatory connective tissue disease, is causally related to eligible service. [108] [107]

Peripheral neuropathy - Critical illness requiring mechanical ventilation support Factor

Last reviewed for CCPS 15 March 2006.

Investigative Documents

Medical Report - Mechanical Ventilation for a Critical Illness - Peripheral Neuropathy [MR9331]

Preliminary questions [32806]

[109]32807

there is some evidence that a critical illness requiring mechanical ventilation support may be a factor in the development of the condition under consideration.

32933 [110] the veteran required mechanical ventilation support for a critical illness at some time.

32808 — the critical illness requiring mechanical ventilation support is an illness or injury which is identifiable.

[111]32809

the veteran required mechanical ventilation support for the identified illness or injury within the thirty days immediately before the clinical onset of the condition under consideration. [112]

32810 — the veteran has established the causal connection between the critical illness requiring mechanical ventilation support and VEA service for the clinical onset of the condition under consideration.

32811 — the veteran has established the causal connection between the critical illness requiring mechanical ventilation support and operational service for the clinical onset of the condition under consideration.

or

32812 — the veteran has established the causal connection between the critical illness requiring mechanical ventilation support and eligible service for the clinical onset of the condition under consideration.

Clinical onset and operational service [32811]

32813 — the identified illness or injury, a critical illness requiring mechanical ventilation support, is causally related to operational service. [113] [114]

Clinical onset and eligible service [32812]

32814 — the identified illness or injury, a critical illness requiring mechanical ventilation support, is causally related to eligible service. [115] [114]

Peripheral neuropathy - Diabetes mellitus Factor

Last reviewed for CCPS 15 March 2006.

Preliminary questions [32682]

489 — the veteran has diabetes mellitus.

10547 [116] the veteran has insulin dependent diabetes mellitus (type 1).

or

[117]10548

the veteran has non-insulin dependent diabetes mellitus (type 2).

[118]28495

the veteran had the identified illness or injury at the time of the clinical onset of the condition under consideration. [119]

12680 — the veteran has established the causal connection between the diabetes mellitus and VEA service for the clinical onset of condition under consideration.

12681 — the veteran has established the causal connection between the diabetes mellitus and operational service for the clinical onset of condition under consideration.

or

12682 — the veteran has established the causal connection between the diabetes mellitus and eligible service for the clinical onset of condition under consideration.

Clinical onset and operational service [12681]

17527 — the identified illness or injury, a type of diabetes mellitus, is causally related to operational service. [120] [121]

Clinical onset and eligible service [12682]

17528 — the identified illness or injury, a type of diabetes mellitus, is causally related to eligible service. [122] [121]

Peripheral neuropathy - Electrical or thermal burn Factor

Last reviewed for CCPS 15 March 2006.

Investigative Documents

Claimant Report - Thermal or electrical burns - Peripheral neuropathy [CR9218]

[123] Medical Report - Thermal or electrical burns - Peripheral neuropathy [MR9287]

Preliminary questions [32903]

[124]32904

there is some evidence that an electrical burn or thermal burn may be a factor in the development of the condition under consideration.

32905 [125] the veteran had an electrical burn or thermal burn as specified in the Statements of Principles for peripheral neuropathy within the thirty days immediately before the clinical onset of the condition under consideration.

32908 — the veteran has established the causal connection between the electrical burn or thermal burn and VEA service for the clinical onset of peripheral neuropathy.

32909 — the veteran has established the causal connection between the electrical burn or thermal burn and operational service for the clinical onset of peripheral neuropathy.

or

32910 — the veteran has established the causal connection between the electrical burn or thermal burn and eligible service for the clinical onset of peripheral neuropathy.

Clinical onset and operational service [32909]

[126]32914

the veteran's electrical or thermal burn as specified in the Statements of Principles for peripheral neuropathy within the thirty days immediately before the clinical onset of the condition under consideration is an identifiable injury.

32915 — the identified illness or injury, an electrical or thermal burn, is causally related to operational service. [127]

Clinical onset and eligible service [32910]

[128]32914

the veteran's electrical or thermal burn as specified in the Statements of Principles for peripheral neuropathy within the thirty days immediately before the clinical onset of the condition under consideration is an identifiable injury.

32916 — the identified illness or injury, an electrical or thermal burn, is causally related to eligible service. [129] [130]

Peripheral neuropathy - Exposure to a specified chemical Factor

Last reviewed for CCPS 15 March 2006.

Investigative Documents

Claimant Report - Exposure to a Specified Chemical  - Peripheral neuropathy [CR9220]

Preliminary questions [32815]

[131]32816

there is some evidence that inhaling, ingesting, or having cutaneous contact with a specified chemical may be a factor in the development of the condition under consideration.

32817 — the veteran has established the causal connection between inhaling, ingesting, or having cutaneous contact with a specified chemical and VEA service for the clinical onset of the condition under consideration.

32818 — the veteran has established the causal connection between inhaling, ingesting, or having cutaneous contact with a specified chemical and operational service for the clinical onset of the condition under consideration.

or

32819 — the veteran has established the causal connection between inhaling, ingesting, or having cutaneous contact with a specified chemical and eligible service for the clinical onset of the condition under consideration.

Clinical onset and operational service [32818]

32820 [132] the veteran experienced inhalation, ingestion, or having cutaneous contact with a specified chemical on at least 30 occasions at some time.

[133]32821

the veteran experienced inhalation, ingestion, or having cutaneous contact with a specified chemical on at least 30 occasions within the six months before the clinical onset of the condition under consideration.

[134]32822

operational service made a material contribution to the veteran inhaling, ingesting or having cutaneous contact with a specified chemical on at least thirty occasions within the six months before the clinical onset of the condition under consideration.

[135]32823

the veteran's inhaling, ingesting or having cutaneous contact with a specified chemical on at least thirty occasions, which was materially contributed by operational service, was due to the veteran's serious default, wilful act or serious breach of discipline.

or

[89]35717

the veteran experienced inhalation, ingestion, or having cutaneous contact with methyl bromide within the thirty day before the clinical onset of the condition under consideration.

[136]35718

on operational service, the veteran experienced inhalation, ingestion, or having cutaneous contact with methyl bromide within the thirty day before the clinical onset of the condition under consideration.

[137]35719

the veteran's inhaling, ingesting or having cutaneous contact with methyl bromide on operational service was due to the veteran's serious default, wilful act or serious breach of discipline.

Clinical onset and eligible service [32819]

[75]32820

the veteran experienced inhalation, ingestion, or having cutaneous contact with a specified chemical on at least 30 occasions at some time.

[133]32821

the veteran experienced inhalation, ingestion, or having cutaneous contact with a specified chemical on at least 30 occasions within the six months before the clinical onset of the condition under consideration.

[134]32827

eligible service made a material contribution to the veteran inhaling, ingesting or having cutaneous contact with a specified chemical on at least thirty occasions within the six months before the clinical onset of the condition under consideration.

[138]32824

the veteran's inhaling, ingesting or having cutaneous contact with a specified chemical on at least thirty occasions, which was materially contributed by eligible service, was due to the veteran's serious default, wilful act or serious breach of discipline. [89]

Peripheral neuropathy - Exposure to a volatile substance Factor

Last reviewed for CCPS 15 March 2006.

Investigative Documents

Claimant Report - Exposure to a Specified Volatile Substance - Peripheral Neuropathy [CR9257]

Preliminary questions [32829]

[139]32830

there is some evidence that exposure to a volatile substance may be a factor in the development of the condition under consideration.

32831 — the veteran has established the causal connection between exposure to a volatile substance and VEA service for the clinical onset of the condition under consideration.

32834 — the veteran has established the causal connection between exposure to a volatile substance and operational service for the clinical onset of the condition under consideration.

or

32835 — the veteran has established the causal connection between exposure to a volatile substance and eligible service for the clinical onset of the condition under consideration.

Clinical onset and operational service [32834]

32984 [140] the veteran was exposed to a volatile substance as specified in the reasonable hypothesis Statement of Principles for peripheral neuropathy on at least 30 occasions within a continuous period of six months at some time.

[141]35740

where the veteran was exposed to a volatile substance as specified in the reasonable hypothesis Statement of Principles for peripheral neuropathy on at least 30 occasions within a continuous period of six months, the clinical onset of peripheral neuropathy occurred within three months of that period.

[142]32836

operational service made a material contribution to the veteran's exposure to a volatile substance as specified in the reasonable hypothesis Statement of Principles for peripheral neuropathy on at least 30 occasions within a continuous period of six months, where the clinical onset of peripheral neuropathy occurred within three months of that period.

[143]32837

the veteran's exposure to a volatile substance as specified in the reasonable hypothesis Statement of Principles for peripheral neuropathy on at least 30 occasions within a continuous period of six months, which was materially contributed by operational service, was due to the veteran's serious default, wilful act or serious breach of discipline.

Clinical onset and eligible service [32835]

[89]32985

the veteran was exposed to a volatile substance as specified in the balance of probabilities Statement of Principles for peripheral neuropathy on at least 30 occasions within a continuous period of six months at some time.

[144]32839

where the veteran was exposed to a volatile substance as specified in the balance of probabilities Statement of Principles for peripheral neuropathy on at least 30 occasions within a continuous period of six months, the clinical onset of peripheral neuropathy occurred within three months of that period.

[145]32840

eligible service made a material contribution to the veteran's exposure to a volatile substance as specified in the balance of probabilities Statement of Principles for peripheral neuropathy on at least 30 occasions within a continuous period of six months, where the clinical onset of peripheral neuropathy occurred within three months of that period.

[146]32838

the veteran's exposure to a volatile substance as specified in the balance of probabilities Statement of Principles for peripheral neuropathy on at least 30 occasions within a continuous period of six months, which was materially contributed by eligible service, was due to the veteran's serious default, wilful act or serious breach of discipline. [89]

Peripheral neuropathy - Exposure to TCDD Factor

Last reviewed for CCPS 15 March 2006.

Investigative Documents

Claimant Report - Exposure to a Chemical Agent Contaminated By 2,3,7,8 TCDD (Dioxin) [CR9258]

Preliminary questions [35743]

[147]35744

there is some evidence that exposure to a chemical agent contaminated by TCCD may be a factor in the development of the condition under consideration.

35745 [148] the veteran experienced inhalation, ingestion, or having cutaneous contact with a chemical agent contaminated by TCCD within the thirty days before the clinical onset of the condition under consideration.

35746 — the veteran has established the causal connection between inhalation, ingestion, or having cutaneous contact with a chemical agent contaminated by TCCD and VEA service for the clinical onset of peripheral neuropathy.

35747 — the veteran has established the causal connection between inhalation, ingestion, or having cutaneous contact with a chemical agent contaminated by TCCD and operational service for the clinical onset of peripheral neuropathy.

or

35748 — the veteran has established the causal connection between inhalation, ingestion, or having cutaneous contact with a chemical agent contaminated by TCCD and eligible service for the clinical onset of peripheral neuropathy.

Clinical onset and operational service [35747]

[149]35749

on operational service, the veteran experienced inhalation, ingestion, or having cutaneous contact with a chemical agent contaminated by TCCD within the thirty days before the clinical onset of the condition under consideration.

[150]35752

the veteran's inhalating, ingesting, or having cutaneous contact with a chemical agent contaminated by TCCD within the thirty days before the clinical onset of the condition under consideration, on operational service, was due to the veteran's serious default, wilful act or serious breach of discipline.

Clinical onset and eligible service [35748]

[75]35750

on eligible service, the veteran experienced inhalation, ingestion, or having cutaneous contact with a chemical agent contaminated by TCCD within the thirty days before the clinical onset of the condition under consideration.

[151]35751

as a causal result of eligible service, the veteran experienced inhalation, ingestion, or having cutaneous contact with a chemical agent contaminated by TCCD within the thirty days before the clinical onset of the condition under consideration.

[152]35753

the veteran's inhalating, ingesting, or having cutaneous contact with a chemical agent contaminated by TCCD within the thirty days before the clinical onset of the condition under consideration, on eligible service, was due to the veteran's serious default, wilful act or serious breach of discipline. [75]

Peripheral neuropathy - Hypothyroidism Factor

Last reviewed for CCPS 15 March 2006.

Preliminary questions [31406]

22370 [153] there is some evidence that hypothyroidism may be a factor in the development of the condition under consideration.

8806 [153] the veteran has had hypothyroidism at some time.

9450 — hypothyroidism means a disease state characterised by a reduction in circulating thyroid hormones. [Default true]

20856 [154] the veteran had the identified illness or injury, a type of hypothyroidism, at the time of the clinical onset of the condition under consideration. [155]

31407 — the veteran has established the causal connection between hypothyroidism and VEA service for the clinical onset of the condition under consideration.

31408 — the veteran has established the causal connection between hypothyroidism and operational service for the clinical onset of the condition under consideration.

or

31409 — the veteran has established the causal connection between hypothyroidism and eligible service for the clinical onset of the condition under consideration.

Clinical onset and operational service [31408]

8811 — the identified illness or injury, a type of hypothyroidism, is causally related to operational service. [156] [157]

Clinical onset and eligible service [31409]

8812 — the identified illness or injury, a type of hypothyroidism, is causally related to eligible service. [158] [157]

Peripheral neuropathy - Inability to obtain appropriate clinical management for peripheral neuropathy Factor

Last reviewed for CCPS 15 March 2006.

Investigative Documents

Medical Report - Inability to Obtain Appropriate Clinical Management - [GQACM]

Preliminary questions [32750]

11109 — the condition under consideration has been accepted on the basis of inability to obtain appropriate clinical management for the condition under consideration.

[159]7066

there is some evidence that an inability to obtain appropriate clinical management for the condition under consideration may be a factor in the worsening of the condition under consideration.

7334 [160] the clinical onset of the condition under consideration occurred after the end of the veteran's last period of VEA service.

[161]7335

the condition under consideration permanently worsened.

[162]7378

the veteran was unable to obtain appropriate clinical management for the condition under consideration at some time.

7379 [163] the inability to obtain appropriate clinical management for the condition under consideration contributed to the clinical worsening of the condition under consideration.

11234 — the veteran has established the causal connection between the inability to obtain appropriate clinical management for the condition under consideration and VEA service for the clinical worsening of the condition under consideration.

11235 — the veteran has established the causal connection between the inability to obtain appropriate clinical management for the condition under consideration and operational service for the clinical worsening of the condition under consideration.

or

11236 — the veteran has established the causal connection between the inability to obtain appropriate clinical management for the condition under consideration and eligible service for the clinical worsening of the condition under consideration.

Clinical worsening and operational service [11235]

[164]7384

the veteran was unable to obtain appropriate clinical management for the condition under consideration, which contributed to the clinical worsening of the condition under consideration, during operational service.

[165]21084

the veteran was unable to obtain appropriate clinical management for the condition under consideration, which contributed to the clinical worsening of the condition under consideration, during operational service, as a causal result of operational service.

[166]7387

the veteran's inability to obtain appropriate clinical management for the condition under consideration during operational service was due to the veteran's serious default, wilful act or serious breach of discipline.

or

[75]7389

the veteran was unable to obtain appropriate clinical management for the condition under consideration, which contributed to the clinical worsening of the condition under consideration, because of an illness or injury which is identifiable.

7390 — the identified illness or injury which prevented the veteran from obtaining appropriate clinical management for the condition under consideration is causally related to operational service. [167] [168]

[169]7392

the clinical onset of the condition under consideration occurred prior to that part of operational service to which the identified illness or injury that prevented the veteran from obtaining appropriate clinical management for the condition under consideration is causally related.

Clinical worsening and eligible service [11236]

[170]7385

the veteran was unable to obtain appropriate clinical management for the condition under consideration, which contributed to the clinical worsening of the condition under consideration, during eligible service.

[171]7386

the veteran was unable to obtain appropriate clinical management for the condition under consideration, which contributed to the clinical worsening of the condition under consideration, during eligible service, as a causal result of eligible service.

[172]7388

the veteran's inability to obtain appropriate clinical management for the condition under consideration during eligible service was due to the veteran's serious default, wilful act or serious breach of discipline.

or

[75]7389

the veteran was unable to obtain appropriate clinical management for the condition under consideration, which contributed to the clinical worsening of the condition under consideration, because of an illness or injury which is identifiable.

7391 — the identified illness or injury which prevented the veteran from obtaining appropriate clinical management for the condition under consideration is causally related to eligible service. [167] [168]

[173]7393

the clinical onset of the condition under consideration occurred prior to that part of eligible service to which the identified illness or injury that prevented the veteran from obtaining appropriate clinical management for the condition under consideration is causally related. [174]

Peripheral neuropathy - Inhalant abuse or inhalant dependence Factor

Last reviewed for CCPS 15 March 2006.

Preliminary questions [35721]

35722 [175] there is some evidence that inhalant abuse or inhalant dependence may be a factor in the development of the condition under consideration.

35723 [176] the veteran has had inhalant abuse or inhalant dependence at some time.

35724 [177] the veteran had inhalant abuse or inhalant dependence at the time of the clinical onset of the condition under consideration. [178]

35725 — the veteran has established the causal connection between the inhalant abuse or inhalant dependence and VEA service for the clinical onset of peripheral neuropathy.

35726 — the veteran has established the causal connection between the inhalant abuse or inhalant dependence and operational service for the clinical onset of peripheral neuropathy.

or

35727 — the veteran has established the causal connection between the inhalant abuse or inhalant dependence and eligible service for the clinical onset of peripheral neuropathy.

Clinical onset and operational service [35726]

35728 — the inhalant abuse or inhalant dependence is causally related to operational service. [179] [180]

Clinical onset and eligible service [35727]

35729 — the inhalant abuse or inhalant dependence is causally related to eligible service. [181] [180]

Peripheral neuropathy - Malignant neoplasm Factor

Last reviewed for CCPS 15 March 2006.

Investigative Documents

Medical Report - Malignant Neoplasm - Peripheral Neuropathy [MR9330]

Preliminary questions [32692]

[182]32693

there is some evidence that a malignant neoplasm, other than non-melanotic malignant neoplasm of the skin, may be a factor in the development of the condition under consideration.

32929 [183] the veteran has had a malignant neoplasm, other than non-melanotic malignant neoplasm of the skin, at some time.

32694 — the veteran's malignant neoplasm other than non-melanotic malignant neoplasm of the skin, is an illness or injury which is identifiable.

[184]32695

the veteran had the identified illness or injury, a malignant neoplasm other than non-melanotic malignant neoplasm of the skin, at the time of the clinical onset of the condition under consideration. [185]

32696 — the veteran has established the causal connection between the malignant neoplasm and VEA service for the clinical onset of the condition under consideration.

32697 — the veteran has established the causal connection between the malignant neoplasm and operational service for the clinical onset of the condition under consideration.

or

32698 — the veteran has established the causal connection between the malignant neoplasm and eligible service for the clinical onset of the condition under consideration.

Clinical onset and operational service [32697]

32699 — the identified illness or injury, a malignant neoplasm other than non-melanotic malignant neoplasm of the skin, is causally related to operational service. [186] [187]

Clinical onset and eligible service [32698]

32700 — the identified illness or injury, a malignant neoplasm other than non-melanotic malignant neoplasm of the skin, is causally related to eligible service. [188] [187]

Peripheral neuropathy - Poisoning with an organic toxin or a specified metal Factor

Last reviewed for CCPS 15 March 2006.

Investigative Documents

Medical Report - Poisoning with an Organic Toxin or a Specified Metal - Peripheral Neuropathy [MR9332]

Preliminary questions [32864]

[189]32865

there is some evidence that poisoning with an organic toxin or a specified metal may be a factor in the development of the condition under consideration.

35741 [190] the veteran demonstrated clinical, haematological or biochemical evidence of poisoning with an organic toxin or a specified metal at some time.

[191]32866

the veteran was poisoned with an organic toxin or a specified metal, as demonstrated by clinical, haematological or biochemical evidence, within the 30 days before the clinical onset of the condition under consideration.

32868 — the veteran has established the causal connection between poisoning with an organic toxin or a specified metal and VEA service for the clinical onset of peripheral neuropathy.

32869 — the veteran has established the causal connection between poisoning with an organic toxin or a specified metal and operational service for the clinical onset of peripheral neuropathy.

or

32870 — the veteran has established the causal connection between poisoning with an organic toxin or a specified metal and eligible service for the clinical onset of peripheral neuropathy.

Clinical onset and operational service [32869]

[192]32871

on operational service, the veteran was poisoned with an organic toxin or a specified metal, as demonstrated by clinical, haematological or biochemical evidence, within the 30 days before the clinical onset of the condition under consideration.

[193]32872

the veteran's poisoning with an organic toxin or a specified metal, as demonstrated by clinical, haematological or biochemical evidence, on operational service, was due to the veteran's serious default, wilful act or serious breach of discipline.

or

[89]32873

the veteran was poisoned with an organic toxin or a specified metal, as demonstrated by clinical, haematological or biochemical evidence, within the 30 days before the clinical onset of the condition under consideration as a consequence of an illness or injury which is identifiable.

32874 — the identified illness or injury which caused the poisoning with an organic toxin or a specified metal is causally related to operational service. [194]

Clinical onset and eligible service [32870]

[195]32876

on eligible service, the veteran was poisoned with an organic toxin or a specified metal, as demonstrated by clinical, haematological or biochemical evidence, within the 30 days before the clinical onset of the condition under consideration.

[196]32877

as a causal result of eligible service, the veteran was poisoned with an organic toxin or a specified metal, as demonstrated by clinical, haematological or biochemical evidence, within the 30 days before the clinical onset of the condition under consideration.

[197]32878

the veteran's poisoning with an organic toxin or a specified metal, as demonstrated by clinical, haematological or biochemical evidence, on eligible service, was due to the veteran's serious default, wilful act or serious breach of discipline.

or

[89]32873

the veteran was poisoned with an organic toxin or a specified metal, as demonstrated by clinical, haematological or biochemical evidence, within the 30 days before the clinical onset of the condition under consideration as a consequence of an illness or injury which is identifiable.

32875 — the identified illness or injury which caused the poisoning with an organic toxin or a specified metal is causally related to eligible service. [198] [199]

Peripheral neuropathy - Treatment with a drug from list 1 Factor

Last reviewed for CCPS 15 March 2006.

Investigative Documents

Medical Report - Drug Causing Peripheral Neuropathy - Peripheral neuropathy [MR9293]

Preliminary questions [32926]

[200]32927

there is some evidence that being treated with a drug from Specified List 1 may be a factor in the development of the condition under consideration.

32937 [201] the veteran was being treated with a drug from Specified List 1 for treatment of an illness or injury which is identifiable.

[202]32934

the identified illness or injury, for which the veteran was being treated with a drug from Specified List 1, is a condition for which the drug cannot be ceased or substituted.

[203]32928

for the identified illness or injury, the veteran was being treated with a drug from Specified List 1, which could not be ceased or substituted, at the time of the clinical onset of the condition under consideration.

32938 — the veteran has established the causal connection between being treated with a drug from Specified List 1 and VEA service for the clinical onset of peripheral neuropathy.

32939 — the veteran has established the causal connection between being treated with a drug from Specified List 1 and operational service for the clinical onset of peripheral neuropathy.

or

32940 — the veteran has established the causal connection between being treated with a drug from Specified List 1 and eligible service for the clinical onset of peripheral neuropathy.

Clinical onset and operational service [32939]

32935 — the identified illness or injury, for which the veteran was being treated with a drug from Specified List 1, is causally related to operational service. [204] [205]

Clinical onset and eligible service [32940]

[206]35731

the identified illness or injury was treated with a drug from Specified List 1 which is available for eligible service cases. [207]

32936 — the identified illness or injury, for which the veteran was being treated with a drug from Specified List 1, is causally related to eligible service. [208] [205]

Peripheral neuropathy - Treatment with a drug from list 2 Factor

Last reviewed for CCPS 15 March 2006.

Investigative Documents

Medical Report - Drug Causing Peripheral Neuropathy - Peripheral neuropathy [MR9293]

Preliminary questions [32944]

[200]32945

there is some evidence that being treated with a drug from Specified List 2 may be a factor in the development of the condition under consideration.

32946 [209] the veteran was being treated with a drug from Specified List 2 for treatment of an illness or injury which is identifiable.

[210]32947

for the identified illness or injury, the veteran was being treated with a drug from Specified List 2 at the time of the clinical onset of the condition under consideration.

32948 — the veteran has established the causal connection between being treated with a drug from Specified List 2 and VEA service for the clinical onset of peripheral neuropathy.

32949 — the veteran has established the causal connection between being treated with a drug from Specified List 2 and operational service for the clinical onset of peripheral neuropathy.

or

32950 — the veteran has established the causal connection between being treated with a drug from Specified List 2 and eligible service for the clinical onset of peripheral neuropathy.

Clinical onset and operational service [32949]

32951 — the identified illness or injury, for which the veteran was being treated with a drug from Specified List 2, is causally related to operational service. [211] [212]

Clinical onset and eligible service [32950]

[213]35736

the identified illness or injury was treated with a drug from Specified List 2 which is available for eligible service cases. [214]

32952 — the identified illness or injury, for which the veteran was being treated with a drug from Specified List 2, is causally related to eligible service. [215] [212]

Peripheral neuropathy - Treatment with cisplatin Factor

Last reviewed for CCPS 15 March 2006.

Investigative Documents

Medical Report - Drug Causing Peripheral Neuropathy - Peripheral neuropathy [MR9293]

Preliminary questions [32953]

[200]32954

there is some evidence that treatment with cisplatin may be a factor in the development of the condition under consideration.

32955 [216] the veteran was treated with cisplatin for an illness or injury which is identifiable.

[217]32956

for the identified illness or injury, the veteran was treated with cisplatin within the six months immediately before the clinical onset of the condition under consideration. [218]

32957 — the veteran has established the causal connection between the treatment with cisplatin and VEA service for the clinical onset of peripheral neuropathy.

32958 — the veteran has established the causal connection between the treatment with cisplatin and operational service for the clinical onset of peripheral neuropathy.

or

32959 — the veteran has established the causal connection between the treatment with cisplatin and eligible service for the clinical onset of peripheral neuropathy.

Clinical onset and operational service [32958]

32960 — the identified illness or injury which required treatment with cisplatin is causally related to operational service. [219] [220]

Clinical onset and eligible service [32959]

32961 — the identified illness or injury which required treatment with cisplatin is causally related to eligible service. [221] [220]